Manchester, NH-based company developing non-systemic, non-toxic complex carbohydrate-based new chemical entity codenamed "PAZ320" to lower post-meal elevation of blood glucose.

Manchester, NH-based Boston Therapeutics developing a chewable pill designed to be taken before meals to lower the elevation of blood glucose after the meal.

Innovative chemistry by Boston Therapeutics might help millions affected by diabetes.